Miranda S. Robbins
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells.
Journal: Neural regeneration research
Published: July 14, 2023
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target.
Journal: Neural regeneration research
Published: July 28, 2022
Synaptic tau: A pathological or physiological phenomenon?
Journal: Acta neuropathologica communications
Published: August 11, 2021
Biofunctionalised bacterial cellulose scaffold supports the patterning and expansion of human embryonic stem cell-derived dopaminergic progenitor cells.
Journal: Stem cell research & therapy
Published: June 08, 2021
Microelectrode Arrays for Simultaneous Electrophysiology and Advanced Optical Microscopy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 17, 2020
OptiJ: Open-source optical projection tomography of large organ samples.
Journal: Scientific reports
Published: June 19, 2019
Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
Journal: Acta neuropathologica
Published: July 07, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026